НовостиBenzingaWolfe Research Initiates Coverage On Rapport Therapeutics with Outperform Rating, Announces Price Target of $50 Wolfe Research Initiates Coverage On Rapport Therapeutics with Outperform Rating, Announces Price Target of $50 Benzinga 2026.10.15 12:00 (GMT+0) Открыть на Benzinga Другие новости